Attenello, F. J., D. Mukherjee, G. Datoo, M. J. McGirt, E. Bohan, J. D. Weingart, A. Olivi, A. Quinones-Hinojosa, and H. Brem. Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience. Ann. Surg. Oncol. 15:2887–2893, 2004.
Azzabi, A., A. N. Hughes, P. M. Calvert, E. R. Plummer, R. Todd, M. J. Griffin, M. J. Lind, M. A. Araveyas, C. Kelly, K. Fishwick, A. H. Calvert, and A. V. Boddy. Phase I study of temozolomide plus paclitaxel in patients with advanced malignant melanoma and associated in vitro investigations. Br. J. Cancer 92:1006–1012, 2005.
Brem, S., B. Tyler, K. Li, G. Pradilla, F. Legnani, J. Caplan, and H. Brem. Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model. Cancer Chemother. Pharmacol. 60:643–650, 2007.
Bruyère, C., C. Lonez, A. Duray, S. Cludts, J. M. Ruysschaert, S. Saussez, P. Yeaton, R. Kiss, and T. Mijatovic. Considering temozolomide as a novel potential treatment for esophageal cancer. Cancer 117:2004–2016, 2011.
Cahan, M. A., K. A. Walter, O. M. Colin, and H. Brem. Cytotoxicity of taxol in vitro against human and rat malignant brain tumors. Cancer Chemother. Pharmacol. 33:441–444, 1994.
Fan, X., S. Ni, H. Qi, X. Wang, C. Wang, and Y. Liu. Biodegradable microfibers deliver the antitumor drug temozolomide to glioma C6 cells in vitro. Pharmazie 65(11):830–834, 2010.
Gururangan, S., L. Cokgor, J. N. Rich, S. Edwards, M. L. Affronti, J. A. Quinn, J. E. Herndon, II, J. M. Provenzale, R. E. McLendon, S. Tourt-Uhlig, J. H. Sampson, V. Stafford-Fox, S. Zaknoen, M. Early, A. H. Friedman, and H. S. Friedman. Phase I study of Gliadel wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas. Neuro Oncol. 3:246–250, 2001.
Harn, H. J., S. Z. Lin, P. C. Lin, C. Y. Liu, P. Y. Liu, L. F. Chang, S. Y. Yen, D. K. Hsieh, F. C. Liu, D. F. Tai, and T. W. Chiou. Local interstitial delivery of z-butylidenephthalide by polymer wafers against malignant human gliomas. Neuro Oncol. 13:635–648, 2011.
Kelland, L. R., and G. Abel. Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and -resistant human ovarian carcinoma cell lines. Cancer Chemother. Pharmacol. 30:444–450, 1992.
Liebmann, J. E., J. Fisher, D. Teague, and J. A. Cook. Sequence dependence of paclitaxel (Taxol) combined with cisplatin or alkylators in human cancer cells. Oncol. Res. 6:25–31, 1994.
Martin, W., E. Lewis, and A. Nicol. Local risk factors for implant therapy. Int. J. Oral Maxillofac. Implants 24:28–38, 2009.
Pan, E., S. B. Mitchell, and J. S. Tsai. A retrospective study of the safety of BCNU wafers with concurrent temozolomide and radiotherapy and adjuvant temozolomide for newly diagnosed glioblastoma patients. J. Neuro Oncol. 88:353–357, 2008.
Perry, J., A. Chambers, K. Spithoff, and N. Laperriere. Gliadel wafers in the treatment of malignant glioma: a systematic review. Curr. Oncol. 14:189–194, 2007.
Qi, H., P. Hu, J. Xu, and A. Wang. Encapsulation of drug reservoirs in fibers by emulsion electrospinning: morphology characterization and preliminary release assessment. Biomacromolecules 7:2327–2330, 2006.
Silber, J. R., M. S. Bobola, S. Ghatan, A. Blank, D. D. Kolstoe, and M. S. Berger. O6-methylguanine-DNA methyltransferase activity in adult gliomas: relation to patient and tumor characteristics. Cancer Res. 58:1068–1073, 1998.
Smith, L. A., and P. X. Ma. Nano-fibrous scaffolds for tissue engineering. Colloids Surf. B Biointerfaces. 39:125–131, 2004.
Stupp, R., M. Hegi, and M. Weller. Neuro-oncology, a decade of temozolomide and beyond. Expert Rev. Anticancer Ther. 10:1675–1677, 2010.
Su, Y., X. Li, Y. Liu, Q. Su, M. L. Qiang, and X. Mo. Encapsulation and controlled release of heparin from electrospun poly(l-lactide-co-epsilon-caprolactone) nanofibers. J. Biomater. Sci. Polym. Ed. 22:165–177, 2011.
Tominaga, H., M. Ishiyama, F. Ohseto, K. Sasamoto, T. Hamamoto, K. Suzuki, and M. Watanabe. A water-soluble tetrazolium salt useful for colorimetric cell viability assay. Anal. Commun. 36:47–50, 1999.
Tseng, S. H., M. S. Bobola, M. S. Berger, and J. R. Silber. Characterization of paclitaxel (Taxol) sensitivity in human glioma- and medulloblastoma-derived cell lines. Neuro Oncol. 1:101–108, 1999.
Tyler, B., S. Wadsworth, V. Recinos, V. Mehta, A. Vellimana, K. Li, J. Rosenblatt, H. Do, G. L. Gallia, I. M. Siu, R. T. Wicks, M. A. Rudek, M. Zhao, and H. Brem. Local delivery of rapamycin: a toxicity and efficacy study in an experimental malignant glioma model in rats. Neuro Oncol. 13:700–709, 2011.
Wang, P. P., J. Frazier, and H. Brem. Local drug delivery to the brain. Adv. Drug Deliv. Rev. 54:987–1013, 2002.
Wee, S., and W. R. Gombotz. Protein release from alginate matrices. Adv. Drug Deliv. Rev. 31:267–285, 1998.
Yarin, A. L., S. Koombhongse, and D. H. Reneker. Bending instability in electrospinning of nanofibers. J. Appl. Phys. 89:3018–3026, 2001.
You, J. O., and C. A. Peng. Calcium-alginate nanoparticles formed by reverse microemulsion as gene carriers. Macromol. Symp. 219:147–153, 2004.
Zhou, S., X. Liao, Z. Liang, X. Li, X. Deng, and H. Li. Preparation and characterization of biodegradable microspheres containing hepatitis B surface antigen. Macromol. Biosci. 4:47–52, 2004.
Zuo, W. W., M. F. Zhu, W. Yang, H. Yu, Y. M. Chen, and Y. Zhang. Experimental study on relationship between jet instability and formation of beaded fibers during electrospinning. Polym. Eng. Sci. 45:704–709, 2005.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.4